Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease
- PMID: 6273025
- DOI: 10.1111/j.1365-2265.1981.tb00649.x
Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease
Abstract
Two patients with Nelson's syndrome and one patient after bilateral adrenalectomy for Cushing's disease, without any evidence of Nelson's syndrome, were studied with respect to the effect of hydrocortisone, naloxone and valproic acid (a GABA transaminase inhibitor) on ACTH secretion. Hydrocortisone suppressed plasma ACTH concentrations to normal in the patient without Nelson's syndrome, but failed to do so in the two patients with Nelson's syndrome. Naloxone and valproic acid caused a decline in plasma ACTH concentrations in the patients with Nelson's syndrome, but produced no change in the patient without Nelson's syndrome. Secretion of ACTH may thus be influenced by both opiate peptide and by gamma aminobutyric acid, as well as by the cortisol concentration, these agents may act at different sites to inhibit ACTH release by the tumour.
Similar articles
-
Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.Clin Endocrinol (Oxf). 2004 Jun;60(6):765-72. doi: 10.1111/j.1365-2265.2004.02052.x. Clin Endocrinol (Oxf). 2004. PMID: 15163342
-
Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.J Clin Endocrinol Metab. 1986 May;62(5):1020-6. doi: 10.1210/jcem-62-5-1020. J Clin Endocrinol Metab. 1986. PMID: 3007552
-
[Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?].Cas Lek Cesk. 1990 May 25;129(21):645-9. Cas Lek Cesk. 1990. PMID: 2164450 Czech.
-
The Nelson's syndrome... revisited.Pituitary. 2004;7(4):209-15. doi: 10.1007/s11102-005-1403-y. Pituitary. 2004. PMID: 16132203 Review.
-
Nelson's Syndrome.Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1392-6. doi: 10.1590/s0004-27302007000800026. Arq Bras Endocrinol Metabol. 2007. PMID: 18209878 Review.
Cited by
-
Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.J Endocrinol Invest. 1983 Aug;6(4):305-6. doi: 10.1007/BF03347595. J Endocrinol Invest. 1983. PMID: 6315806
-
The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.Klin Wochenschr. 1988 Aug 1;66(15):686-9. doi: 10.1007/BF01726927. Klin Wochenschr. 1988. PMID: 2845188 Clinical Trial.
-
Drugs and HPA axis.Pituitary. 2008;11(2):219-29. doi: 10.1007/s11102-008-0114-6. Pituitary. 2008. PMID: 18404384 Review.
-
Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.J Endocrinol Invest. 1984 Apr;7(2):93-6. doi: 10.1007/BF03348396. J Endocrinol Invest. 1984. PMID: 6327800 Clinical Trial.
-
Management of Nelson's Syndrome.Medicina (Kaunas). 2022 Nov 2;58(11):1580. doi: 10.3390/medicina58111580. Medicina (Kaunas). 2022. PMID: 36363537 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical